Jacobs Levy Equity Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
BG
Jacobs Levy Equity Management's BSX Position: Q3 2022 in Review
Jacobs Levy Equity Management sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 6,423 shares — an estimated $239K sold.
Jacobs Levy Equity Management first reported a position in BSX in Q2 2013 and held it in 15 quarters. The position peaked at $24.1M in Q4 2014. 866 funds tracked by Wall St. Rank hold BSX as of Q3 2022.
- Jacobs Levy Equity Management reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
- Jacobs Levy Equity Management sold 6,423 Boston Scientific shares in Q3 2022, an estimated $239K.
- Jacobs Levy Equity Management first reported a position in Boston Scientific in Q2 2013 and held it in 15 quarters.
- Jacobs Levy Equity Management's Boston Scientific position peaked at $24.1M in Q4 2014.
- 866 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2022, filed 15 Nov 2022.